Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

医学 雄激素剥夺疗法 前列腺癌 临床终点 泌尿科 放射治疗 内科学 氟他胺 随机对照试验 随机化 前列腺 危险系数 胃肠病学 肿瘤科 癌症 雄激素受体 置信区间
作者
Bernard Dubray,Julia Salleron,S. Guérif,É. Le Prisé,A. Reynaud-Bougnoux,Jean‐Michel Hannoun‐Lévi,Tan Dat Nguyen,Christophe Hennequin,Jacques Cretin,M. Fayolle-Campana,Jean‐Léon Lagrange,Jean‐Marc Bachaud,D. Azria,Alain Grangirard,P. Pommier,Antoine Simon,Muriel Habibian,Pierre Bey,V. Beckendorf
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (15_suppl): 5021-5021 被引量:31
标识
DOI:10.1200/jco.2016.34.15_suppl.5021
摘要

5021 Background: Multi-center randomized trial to evaluate the addition of 4-month androgen deprivation to high dose radiotherapy in intermediate risk localized prostate adenocarcinoma patients (pts). Methods: eligible pts were randomly assigned to high dose conformal radiotherapy (prostate 80 Gy / 40 fractions; seminal vesicles 46 Gy / 23 fractions) either alone (group RT) or in combination with 4-month androgen deprivation (flutamide + triptorelin starting 2 months before radiotherapy, group AD-RT). Lymphadenectomy was mandatory when the risk of node involvement was > 10% (Partin). The primary endpoint was survival without clinical / biochemical relapse at 5 years. Secondary endpoints included overall survival, toxicity (CTCAE v3) and quality of life (QLQ-C30, PR-25). The a-priori sample size was 450 patients, 225 per arm (0.90 power to detect an increase from 75 to 85%, bilateral α = 0.05). Results: 377 pts were included between September 2003 and June 2010. The inclusions were prematurely closed, due to slow accrual. Intent-to-treat analysis was made for 370 pts (191 RT, 179 AD-RT). Prognostic factors were well balanced between the two arms. The median follow-up duration was 84 months (range: 3 to 132). At 5 years, the probabilities of survival without clinical / biochemical relapse were 76% [95% CI: 69% – 81%] and 84% [78% – 89%] in RT and AD-RT groups, respectively (p = 0.02). Overall survival probabilities were 94% [90% - 97%] and 93% [88% - 96%] respectively (p = 0.54).Cumulative incidence of biochemical failure were 21% [15% – 26%] and 10% [6% – 15%], respectively (p < 0.01). The probabilities of being free of grade 3-4 toxicities were 96% and 95% (p = 0.69) for digestive tract, 93% and 95% (p = 0.44) for urinary tract. Conclusions: 4 months of androgen blockade improves event-free survival at 5 years in pts with intermediate risk prostate adenocarcinoma when treated with high dose radiotherapy. Longer follow-up is required to demonstrate an impact on overall survival. Clinical trial information: EU-20503 / NCT00104741.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青应助w_采纳,获得10
刚刚
玉玊发布了新的文献求助10
1秒前
忘久完成签到,获得积分10
1秒前
话梅完成签到,获得积分10
1秒前
1秒前
英勇安容完成签到,获得积分10
1秒前
moon完成签到,获得积分10
1秒前
liii发布了新的文献求助10
1秒前
1秒前
1秒前
hp571发布了新的文献求助10
2秒前
李靖完成签到 ,获得积分10
2秒前
23333发布了新的文献求助10
2秒前
莫语完成签到 ,获得积分10
2秒前
彭于彦祖应助123采纳,获得30
2秒前
yurun_wu完成签到,获得积分10
3秒前
3秒前
上官若男应助Ai_niyou采纳,获得10
4秒前
jim_hacker发布了新的文献求助30
5秒前
5秒前
小马甲应助玉玊采纳,获得10
6秒前
开放的水壶完成签到,获得积分10
6秒前
GUGE完成签到,获得积分10
6秒前
7秒前
7秒前
8秒前
cza发布了新的文献求助10
8秒前
9秒前
yyyy完成签到,获得积分10
9秒前
吴大王发布了新的文献求助10
10秒前
赎罪完成签到 ,获得积分10
10秒前
今后应助chen采纳,获得10
10秒前
10秒前
hrzmlily完成签到,获得积分10
11秒前
GUGE发布了新的文献求助10
12秒前
12秒前
yyyy发布了新的文献求助10
12秒前
12秒前
w_发布了新的文献求助10
13秒前
一只羊完成签到 ,获得积分20
13秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968964
求助须知:如何正确求助?哪些是违规求助? 3513877
关于积分的说明 11170569
捐赠科研通 3249201
什么是DOI,文献DOI怎么找? 1794692
邀请新用户注册赠送积分活动 875297
科研通“疑难数据库(出版商)”最低求助积分说明 804755